279 related articles for article (PubMed ID: 12756015)
81. [Diagnostic Value of MPV, PDW, PAIg and Their Combination for Megakaryocyte Dysmaturity in Children with Acute Immune Thrombocytopenic Purpura].
Zhang JQ; Hou XH; Hong Q; Chen ZQ; Lu R; Liu SJ; Zhao JT; Hong GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1949-1954. PubMed ID: 31839065
[TBL] [Abstract][Full Text] [Related]
82. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
83. Some viral microRNAs were up-regulated in megakaryocytes incubated with immune thrombocytopenia plasma.
Wang Y; Huang R; Song C; Hu H; Zhang M
Eur J Haematol; 2013 Mar; 90(3):220-7. PubMed ID: 23282244
[TBL] [Abstract][Full Text] [Related]
84. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura: a morphometric and immunohistochemical study on bone marrow biopsies with special emphasis on precursor cells.
Thiele J; von Ammers E; Wagner S; Degel C; Fisher R
Hematol Pathol; 1991; 5(2):75-82. PubMed ID: 1894584
[TBL] [Abstract][Full Text] [Related]
85. Level of IL-16 and Reticulated Platelets Percentage during the Clinical Course of Immune Thrombocytopenic Purpura in Children.
Abd El-Glil RR; Assar EH
Egypt J Immunol; 2015; 22(1):29-40. PubMed ID: 26415370
[TBL] [Abstract][Full Text] [Related]
86. Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count.
Lee-Sundlov MM; Burns RT; Kim TO; Grozovsky R; Giannini S; Rivadeneyra L; Zheng Y; Glabere SH; Kahr WHA; Abdi R; Despotovic JM; Wang D; Hoffmeister KM
Blood; 2021 Dec; 138(23):2408-2424. PubMed ID: 34324649
[TBL] [Abstract][Full Text] [Related]
87. Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.
Wang Q; Wei J; Jia X; Feng X; Ji Z; Ji X; Shao X
BMC Pediatr; 2022 Mar; 22(1):164. PubMed ID: 35354403
[TBL] [Abstract][Full Text] [Related]
88. Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura.
Shirota T; Yamamoto H; Fujimoto H; Harada Y; Okada K; Uchida H; Roppongi H; Hayashi T
Am J Hematol; 1997 Dec; 56(4):272-6. PubMed ID: 9395191
[TBL] [Abstract][Full Text] [Related]
89. Study of CD4
El-Rashedi FH; El-Hawy MA; Helwa MA; Abd-Allah SS
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):8-14. PubMed ID: 28183683
[TBL] [Abstract][Full Text] [Related]
90. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura.
Taub JW; Warrier I; Holtkamp C; Beardsley DS; Lusher JM
Am J Hematol; 1995 Feb; 48(2):104-7. PubMed ID: 7847322
[TBL] [Abstract][Full Text] [Related]
91. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
[TBL] [Abstract][Full Text] [Related]
92. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia.
Zauli G; Catani L; Gibellini D; Re MC; Vianelli N; Colangeli V; Celeghini C; Capitani S; La Placa M
Br J Haematol; 1996 Mar; 92(3):711-7. PubMed ID: 8616042
[TBL] [Abstract][Full Text] [Related]
93. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
94. Prediction of clinical outcome in patients with idiopathic thrombocytopenic purpura by evaluating bone marrow clot CD20+ B lymphocytes and morphological changes of megakaryocytes.
Yamamoto F; Narimatsu H; Ito M; Yamashita S; Kurahashi S; Sugimoto T; Adachi T; Sugiura I
J Clin Exp Hematop; 2008 Apr; 48(1):11-5. PubMed ID: 18434688
[TBL] [Abstract][Full Text] [Related]
95. Serum thrombopoietin level is mainly regulated by megakaryocyte mass rather than platelet mass in human subjects.
Nagasawa T; Hasegawa Y; Shimizu S; Kawashima Y; Nishimura S; Suzukawa K; Mukai H; Hori M; Komeno T; Kojima H; Ninomiya H; Tahara T; Abe T
Br J Haematol; 1998 May; 101(2):242-4. PubMed ID: 9609516
[TBL] [Abstract][Full Text] [Related]
96. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
[TBL] [Abstract][Full Text] [Related]
97. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.
Khodadi E; Asnafi AA; Shahrabi S; Shahjahani M; Saki N
Ann Hematol; 2016 Oct; 95(11):1765-76. PubMed ID: 27236577
[TBL] [Abstract][Full Text] [Related]
98. Response to thrombopoietic agents is related to on-treatment bone marrow megakaryocyte morphology in patients with chronic immune thrombocytopenia.
Hogan M; Geyer JT; Bussel JB
Am J Hematol; 2019 Jul; 94(7):E196-E198. PubMed ID: 31012979
[No Abstract] [Full Text] [Related]
99. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
100. Platelet apoptosis resistance and increased CXCR4 expression in pediatric patients with chronic immune thrombocytopenic purpura.
Wang JD; Ou TT; Wang CJ; Chang TK; Lee HJ
Thromb Res; 2010 Oct; 126(4):311-8. PubMed ID: 20708218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
